[go: up one dir, main page]

GB9416321D0 - Peptides and antibodies and their use in treatment of carcinomas - Google Patents

Peptides and antibodies and their use in treatment of carcinomas

Info

Publication number
GB9416321D0
GB9416321D0 GB9416321A GB9416321A GB9416321D0 GB 9416321 D0 GB9416321 D0 GB 9416321D0 GB 9416321 A GB9416321 A GB 9416321A GB 9416321 A GB9416321 A GB 9416321A GB 9416321 D0 GB9416321 D0 GB 9416321D0
Authority
GB
United Kingdom
Prior art keywords
carcinomas
peptides
antibodies
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9416321A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Holding Ltd
Original Assignee
Peptide Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptide Therapeutics Ltd filed Critical Peptide Therapeutics Ltd
Priority to GB9416321A priority Critical patent/GB9416321D0/en
Publication of GB9416321D0 publication Critical patent/GB9416321D0/en
Priority to PCT/GB1995/001893 priority patent/WO1996005231A1/en
Priority to AU32267/95A priority patent/AU3226795A/en
Pending legal-status Critical Current

Links

GB9416321A 1994-08-12 1994-08-12 Peptides and antibodies and their use in treatment of carcinomas Pending GB9416321D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB9416321A GB9416321D0 (en) 1994-08-12 1994-08-12 Peptides and antibodies and their use in treatment of carcinomas
PCT/GB1995/001893 WO1996005231A1 (en) 1994-08-12 1995-08-10 Peptides and antibodies and their use in treatment of carcinomas
AU32267/95A AU3226795A (en) 1994-08-12 1995-08-10 Peptides and antibodies and their use in treatment of carcinomas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9416321A GB9416321D0 (en) 1994-08-12 1994-08-12 Peptides and antibodies and their use in treatment of carcinomas

Publications (1)

Publication Number Publication Date
GB9416321D0 true GB9416321D0 (en) 1994-10-05

Family

ID=10759787

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9416321A Pending GB9416321D0 (en) 1994-08-12 1994-08-12 Peptides and antibodies and their use in treatment of carcinomas

Country Status (3)

Country Link
AU (1) AU3226795A (en)
GB (1) GB9416321D0 (en)
WO (1) WO1996005231A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6498181B1 (en) 1999-01-06 2002-12-24 Maxim Pharmaceuticals Synergistic tumorcidal response induced by histamine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8913737D0 (en) * 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment

Also Published As

Publication number Publication date
WO1996005231A1 (en) 1996-02-22
AU3226795A (en) 1996-03-07

Similar Documents

Publication Publication Date Title
IL117993A0 (en) Modified anti-icam-1 antibodies and their use in the treatment of inflammation
PL322589A1 (en) Radiotracer-labelled peptides for use in diagnostics and therapy
EP0785276A4 (en) Modification of peptide and protein
HUP9904177A3 (en) Antibody against human parathormone related peptides
IL113844A (en) N-(alpha-ETHYLBENZYL)-3-HYDROXY-2-PHENYLQUINOLINE-4-CARBOXAMIDE AND ITS USE IN THE PREPARATION OF MEDICAMENTS
EP0759071A4 (en) Wt1 monoclonal antibodies and methods of use therefor
EP0693931A4 (en) Immunogenic cancer proteins and peptides and method of use
PL324750A1 (en) Expressive construct p16 and posiibility of using it in treating carcinomas
EP0805161A4 (en) (1-3)-beta-d-glucan-binding protein, antibody that recognizes the protein, and use of the protein and antibody
EP0831793A4 (en) Protein particles for therapeutic and diagnostic use
HUP9901343A3 (en) P53 protein variants and therapeutical uses thereof
EP0786001A4 (en) Chemokine-like proteins and methods of use
GB9419553D0 (en) Polypeptides and their use in the treatment of auto-immune disease
ZA96240B (en) Novel peptides their preparation and use
GB9519710D0 (en) Treatment of particulate material
IL116658A0 (en) Peptides their preparation and use
GB9423372D0 (en) Proteins and their uses
IL128444A0 (en) Conjugated peptides immunological reagent containing same and use thereof for treatment of immunological disorders
GB9514816D0 (en) Substances and their medical use
GB9416321D0 (en) Peptides and antibodies and their use in treatment of carcinomas
EP0841393A4 (en) HUMAN GALECTIN-4-LIKE PROTEIN AND cDNA ENCODING THE SAME
IL112681A0 (en) Opioid peptides for the treatment of pain and use thereof
EP0540575A4 (en) Human meg-csf protein and methods
IL109540A0 (en) Synthetic peptides and their use in tumor diagnosis and therapy
GB9013872D0 (en) Use of protein a and polypeptide components thereof in the treatment of tumours